Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Florida Brain Bank Resource Report Resource Website |
Florida Brain Bank (RRID:SCR_004936) | biomaterial supply resource, brain bank, material resource, tissue bank | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 11, 2023. A service and research oriented network of statewide regional brain bank sites. The intent of the brain bank program is to study brains of persons clinically diagnosed with dementia and provide tissue for research after their deaths. Mt. Sinai Medical Center contracts annually with the State of Florida to operate the primary brain bank. Coordinators at regional brain bank sites in Orlando, Tampa and Pensacola assist in recruiting participants and act as liaisons between the brain bank and participant families. Alzheimer's disease respite care program providers, memory disorder clinics, and model day care programs also recruit brain bank participants. The Florida Brain Bank supports collaborative research programs related to Alzheimer's disease and other degenerative disorders of the brain. | post-mortem, tissue, brain, alzheimer's disease, dementia, clinical, mild cognitive impairment, florida, brain bank, degenerative brain disorder |
is listed by: One Mind Biospecimen Bank Listing has parent organization: State of Florida Alzheimer's Disease Initiative has parent organization: Wien Center For Alzheimer's Disease and Memory Disorders |
Alzheimer's disease, Dementia, Mild Cognitive Impairment | State of Florida Department of Elder Affairs | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_143950 | http://elderaffairs.state.fl.us/english/BrainBank/index.php | SCR_004936 | State of Florida Brain Bank, Florida Alzheimer's Disease Brain Bank | 2026-09-19 12:50:44 | 0 | |||||
|
Alzheimer Europe Resource Report Resource Website 10+ mentions |
Alzheimer Europe (RRID:SCR_003802) | AE | nonprofit organization | A non-governmental organization aimed at raising awareness of all forms of dementia by creating a common European platform through co-ordination and co-operation between Alzheimer organizations throughout Europe. Alzheimer Europe is also a source of information on all aspects of dementia. |
is related to: Greek Association of Alzheimers Disease and Related Disorders is related to: PharmaCog is related to: EMIF is parent organization of: PharmaCog |
Dementia, Alzheimer's disease | European Union | ISNI: 0000 0001 0739 010X, Wikidata: Q16827712, nlx_158313, grid.424021.1 | https://ror.org/029yy6d70 | SCR_003802 | 2026-09-19 12:50:26 | 11 | |||||||
|
reMYND Resource Report Resource Website 1+ mentions |
reMYND (RRID:SCR_003824) | reMYND | commercial organization | Organization that drives the development of disease-modifying treatments against Alzheimer's, Parkinson's, Diabetes and other protein misfolding disorders through two independently managed business units: * Contract Research: The in-vivo Contract Research Organization (CRO) helps its clients to assess the pharmacokinetics and -dynamics of their experimental treatments against Alzheimer's disease. The main focus is on efficacy testing of candidate drugs in reMYND's proprietary Alzheimer mouse models expressing the clinical APP-London allele as single transgene or in combination with clinical alleles of human PS1 and TAU. * Drug Discovery: The Drug Discovery and Development Unit (DDD) focuses on disease-modifying treatments against protein-misfolding disorders, such as Alzheimer's disease (tau), Parkinson's disease (-synuclein), and Diabetes. In addition, reMYND grants licenses and markets commercial kits of RadarScreen, a technology for rapid and cost-effective identification of genotoxic liabilities in early stage drug discovery. reMYND has been substantially supported by grants from IWT and from The Michael J Fox Foundation. | protein misfolding | Alzheimer's disease, Parkinson's disease, Diabetes | IWT ; Michael J. Fox Foundation for Parkinson's Research |
nlx_158130 | SCR_003824 | reMYND NV | 2026-09-19 12:50:26 | 1 | |||||||
|
Amorfix Resource Report Resource Website 1+ mentions |
Amorfix (RRID:SCR_003783) | AMF | commercial organization | Product development company focused on therapeutic products and diagnostic devices targeting misfolded protein diseases. On July, 2015 the company name was changed to ProMIS Neurosciences, Inc. | diagnostic, therapy, alzheimer, protein, misfolded protein disease | Alzheimer's disease, Amyotrophic Lateral Sclerosis, Cancer | Crossref funder ID: 100007611, nlx_158072, grid.422608.a | https://ror.org/045rtab03 | SCR_003783 | Amorfix Life Science, Amorfix Life Sciences Ltd., Amorfix Life Sciences, ProMIS Neurosciences | 2026-09-19 12:50:25 | 2 | |||||||
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-09-19 12:50:28 | 34 | |||||||
|
Innovative Concepts in Drug Development Resource Report Resource Website |
Innovative Concepts in Drug Development (RRID:SCR_003940) | ICDD | commercial organization | A contract research organization (CRO) that are mitochondrial experts, operating mitochondrial function screening platforms by using accepted pharmaceutical innovative technologies. The dynamic analysis of several typical markers of central and mitochondrial metabolism, redox status, or mitochondrial biogenesis are included in the determination of bioenergetic balance in living cells of human origin. These platforms are used to validate the activity of pharmaceuticals, cosmetics and environmental assets xenobiotics on mitochondrial targets associated with the activity or toxicity of these products under the selected models. They specialize in the selection of drugs affecting the progression of neurodegenerative diseases and offer proven models of Huntington's disease, Parkinson's and Alzheimer's, using primary cells of human origin. They have developed and use technology cellulomique and proteomics to identify early response profiles and clinical safety of pharmaceutical products for diseases of the CNS. | contract research organization, mitochondria, drug development, pharmaceutical, drug, model, toxicity, cosmetic, environment | is related to: PharmaCog | Parkinson's disease, Alzheimer's disease, Neurodegenerative disease, Huntington's disease, Central nervous system disease | Commercial | nlx_158326 | SCR_003940 | ICDD-sas | 2026-09-19 12:50:29 | 0 | ||||||
|
Greek Association of Alzheimers Disease and Related Disorders Resource Report Resource Website |
Greek Association of Alzheimers Disease and Related Disorders (RRID:SCR_003938) | GAADRD | nonprofit organization | A non-profit organization whose aim is to offer advice concerning the care of Alzheimer''''s disease patients, information and services for the people affected and their families. Also, to offer mutual help to the family members of the patients in order to reduce the social, economic and emotional cost deriving from the long care of people suffering from dementia. Lastly, the association attempts to publicize the social needs of the population affected and to inform the public in order to be acquainted with the problem. The mission of the Greek Association of Alzheimer''''s Disease is * the early diagnosis of dementia by scientists * the promotion of research * education and training for all the stakeholders * the development of Care Units for patients with Alzheimer''''s Disease * the provision of useful information and advise (24 hour help-line) on dementia problems (caring, legal or financial issues) * the presentation of lectures by health professionals and informal carers, covering all aspects of Alzheimer Disease * and the development of professional seminars during the whole year. | late adult human |
is related to: Alzheimer Europe is related to: PharmaCog is related to: Alzheimers Disease International |
Alzheimer's disease, Dementia, Aging | nlx_158314, grid.428867.7 | https://ror.org/04xqgyf78 | SCR_003938 | Greek Association of Alzheimer Disease and Relative Disorders, Greek Association of Alzheimer Disease and Related Disorders, Alzheimer Hellas, Greek Association of Alzheimer's Disease and Related Disorders | 2026-09-19 12:50:29 | 0 | ||||||
|
Eisai Resource Report Resource Website 10+ mentions |
Eisai (RRID:SCR_003936) | Eisai | commercial organization | A global pharmaceutical company. | pharmaceutical, healthcare, drug, oncology, central nervous system, neurology, medicine | is related to: PharmaCog | Cancer, Epilepsy, Alzheimer's disease, Obesity, Immune-mediated disease, Insomnia | grid.418767.b, Wikidata: Q29123933, nlx_158312, ISNI: 0000 0004 0599 8842 | https://ror.org/0469x1750 | SCR_003936 | Eisai Co. Ltd., EISAI Ltd | 2026-09-19 12:50:29 | 17 | ||||||
|
Alzheimer's Plan Foundation Resource Report Resource Website |
Alzheimer's Plan Foundation (RRID:SCR_004032) | National Institute of Health and Medical Research; Rennes; France | institution | A non-profit registered French charity that provides a research on Alzheimer's disease and related disorders program with the following goals: * create a dynamic national and international collaborative research of the fundamental absorptions, * densify the network of public and private researchers with an attractive policy * install infrastructure basic, clinical and laboratory performing research * promote interaction with the health industries to reduce development time. At the national level the Foundation has implemented measures Research Plan, through: * animation fabric French medical and scientific research, * coordination of research initiatives * the implementation of actions, * support for specific projects. Internationally, the Foundation is at the origin of an international mobilization of researchers, initiated during the French Presidency of the European Union. Called Joint Programming, this pilot initiative involves 23 countries will coordinate their efforts at European level research on neurodegenerative diseases, especially Alzheimer's disease. | late adult human, alzheimer, portal, funding resource | is related to: International Genomics of Alzheimers Project | Alzheimer's disease, Neurodegenerative disease | French Ministry of Higher Education and Research | nlx_158458, Crossref funder ID: 501100007494, grid.478982.8 | https://ror.org/00kr4dx39 | SCR_004032 | Alzheimers Plan Foundation, Fondation Plan Alzheimer | 2026-09-19 12:50:31 | 0 | |||||
|
Proteome Sciences Resource Report Resource Website 1+ mentions |
Proteome Sciences (RRID:SCR_004106) | PS | commercial organization | Commercial company delivering content for personalized medicine in the areas of Biomarker Services, Biomarker Assays, Isobaric and Isotopic Reagents and Proprietary Biomarkers. A global leader in applied proteomics, they use high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases) and to develop rapid assays for testing. The biomarkers discovered in body fluids or tissues are validated, developed and commercialized as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. | protein, peptide, biomarker, pharmaceutical, diagnostic, electrophoretics ltd, electrophoretics, proteomics, assay, isobaric, isotopic, reagent, personalized medicine, mass spectrometry, tandem mass tag | is related to: EMIF | Neurodegenerative disorder, Cancer, Stroke, Alzheimer's disease, Traumatic brain injury | nlx_158582 | SCR_004106 | Proteome Science, Proteome Sciences plc | 2026-09-19 12:50:33 | 3 | |||||||
|
UAB Alzheimer's Disease Center Resource Report Resource Website |
UAB Alzheimer's Disease Center (RRID:SCR_004305) | ADC, UAB ADC | biomaterial supply resource, brain bank, material resource, tissue bank | The UAB Alzheimer's Disease Center provides comprehensive treatment for Alzheimer's patients while also promoting research for the prevention and cure of Alzheimer's disease and related disorders. The ADC is an interdisciplinary program of scientists working in areas including neurology, psychiatry, genetics, and psychology. The Center provides comprehensive treatment and promotes research for the prevention and/or cure of Alzheimer's disease and other related disorders with memory loss and impaired cognition. A major emphasis of research is the maintenance of a clinical research database comprised of neurological, medical, and neuropsychological test data from participants seen in the ADRC Clinical study since 1999, many of whom have been followed for several years in the study. | brain, alzheimer's disease, mild cognitive impairment, brain donation, clinical research database |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Alabama at Birmingham; Alabama; USA |
Alzheimer's disease, Mild Cognitive Impairment, Aging | NIA 1P50 AG16582 | Researchers interested in Alzheimer's disease may access the clinical research data | nlx_143674 | http://main.uab.edu/adc/ http://www.uab.edu/medicine/neurology/alzheimers-disease-center | SCR_004305 | UAB Alzheimer's Disease Center, University of Alabama at Birmingham Alzheimer's Disease Center | 2026-09-19 12:50:35 | 0 | ||||
|
Foundation for the National Institutes of Health Resource Report Resource Website 1000+ mentions |
Foundation for the National Institutes of Health (RRID:SCR_004493) | FNIH | institution | A public charity whose mission is to support the NIH in its mission to improve health, by forming and facilitating public-private partnerships for biomedical research and training. Its vision is Building Partnerships for Discovery and Innovation to Improve Health. The FNIH draws together the world''s foremost researchers and resources, pressing the frontier to advance critical discoveries. They are recognized as the number-one medical research charity in the countryleveraging support, and convening high level partnerships, for the greatest impact on the most urgent medical challenges we face today. Grants are awarded as part of a public-private partnership with the National Heart, Lung, and Blood Institute (NHLBI) on behalf of The Heart Truth in support of women''s heart health education and research. Funding for the Community Action Program is provided by the FNIH through donations from individuals and corporations including The Heart Truth partners Belk Department Stores, Diet Coke, and Swarovski. Successful biomedical research relies upon the knowledge, training and dedication of those who conduct it. Bringing multiple disciplines to bear on health challenges requires innovation and collaboration on the part of scientists. Foundation for NIH partnerships operate in a variety of ways and formats to recruit, train, empower and retain their next generation of researchers. From lectures and multi-week courses, to scholarships and awards through fellowships and residential training programs, their programs respond to the needs of scientists at every level and stage in their careers. | biomedical research |
is related to: Osteoarthritis Biomarkers Project (OABP) is parent organization of: Biomarkers Consortium is parent organization of: Observational Medical Outcomes Partnership is parent organization of: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is parent organization of: Accelerating Medicines Partnership - Alzheimers is parent organization of: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is parent organization of: Genetic Association Information Network (GAIN) |
Type 1 diabetes, Type 2 diabetes, Diabetes, Metabolic disease, Alzheimer's disease, Schizophrenia, Prostate cancer, Demantia, Muscular dystrophy, Tuberculosis, HIV, Parkinson's disease, Osteoarthritis, Age-related eye disease, Visceral leishmaniasis, Undiagnosed disease, Cancer, Non-small cell lung cancer, Malaria, Systemic lupus erythematosus, COVID-19, Acute lymphoblastic leukemia | ISNI: 0000 0000 9836 9834, Wikidata: Q16837497, nlx_143768, Crossref funder ID: 100000009, grid.428807.1 | https://ror.org/00k86s890 | SCR_004493 | Foundation for NIH | 2026-09-19 12:50:38 | 2193 | ||||||
|
Ablynx Resource Report Resource Website 10+ mentions |
Ablynx (RRID:SCR_002940) | Ablynx | material service resource, production service resource, reagent manufacture, service resource | A biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious life-threatening human diseases including inflammation, hematology, oncology and pulmonary disease. | nanobody, protein, antibody fragment, human disease, oncology, hematology, tumor, blood, therapy, therapeutic, pharmaceutical, drug product, drug | Inflammation, Cancer, Pulmonary disease, Thrombosis, Alzheimer's disease, Rheumatoid arthritis, Osteoporosis, Thrombotic thrombocytopenic purpura, Respiratory syncytial virus | nif-0000-30052 | SCR_002940 | 2026-09-19 12:50:08 | 18 | |||||||||
|
CBU Imaging Wiki Resource Report Resource Website 50+ mentions |
CBU Imaging Wiki (RRID:SCR_003014) | CBU Imaging Wiki | data or information resource, portal, topical portal | Portal where neuroimaging studies are carried out using a Siemens 3T Tim Trio Magnetic Resonance Imaging (or MRI) scanner that is wholly dedicated to studies in Cognitive Neuroscience. From emotions and memories to language and learning, functional neuroimaging is being applied in many different areas of Cognitive Neuroscience. In many cases, this research relies upon support from healthy volunteers although neuroimaging studies are also being conducted in various clinical populations, including depression, anxiety, Parkinson's disease and Alzheimer's disease. | neuroimaging, cognitive neuroscience, mri, scanner, neuroscience, emotion, memory, language, learning, functional neuroimaging, clinical, population, human, analysis, software, disease, brain, imaging, fmri, cognition |
is related to: FslAtlasIntegration has parent organization: MRC Cognition and Brain Sciences Unit is parent organization of: MNI brain and the Talairach atlas is parent organization of: MNI brain and the Talairach atlas |
Depressive Disorder, Anxiety, Parkinson's disease, Alzheimer's disease | MRC | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-30307 | SCR_003014 | CBUImaging, MRC CBU Imaging Wiki, MRC Cognition and Brain Sciences Unit Imaging Wiki, Cognition and Brain Sciences Unit Imaging Wiki | 2026-09-19 12:50:09 | 60 | |||||
|
ADNI - Alzheimer's Disease Neuroimaging Initiative Resource Report Resource Website 1000+ mentions |
ADNI - Alzheimer's Disease Neuroimaging Initiative (RRID:SCR_003007) | ADNI | data or information resource, data repository, database, service resource, storage service resource | Database of the results of the ADNI study. ADNI is an initiative to develop biomarker-based methods to detect and track the progression of Alzheimer's disease (AD) that provides access to qualified scientists to their database of imaging, clinical, genomic, and biomarker data. | mri, alzheimer’s disease, cognitive assessment, neuroimaging, disease study, disease progression, biomarker, FASEB list |
is used by: Biomarkers Across Neurodegenerative Diseases is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) is listed by: Consortia-pedia is related to: Alzheimers Association is related to: Alzheimers Drug Discovery Foundation |
Alzheimer's disease, Mild Cognitive Impairment, Elderly control, Traumatic brain injury, Post-Traumatic Stress Disorder, Aging | NIA U01AG024904; NIA P30AG010129; NIA K01AG030514 |
Application required, Account required, This resource is available to the scientific community | SciRes_000144, nif-0000-00516 | http://adni.loni.usc.edu/, http://www.nitrc.org/projects/adni/, http://www.adni3.org/ | http://www.loni.ucla.edu/ADNI/ | SCR_003007 | Alzheimers Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Disease Neuroimaging Initiative | 2026-09-19 12:50:09 | 4635 | |||
|
Stereology Resource Center Resource Report Resource Website 1+ mentions |
Stereology Resource Center (RRID:SCR_003137) | SRC | commercial organization | A company of professionally trained stereologists, bioscientists, computer engineers, educators, and support personnel that provides comprehensive neurostereology products and services to the global bioscience community. These products and services include: stereology and image analysis software, digital imaging technology, turnkey stereologer solutions, comprehensive stereology and image analysis/image processing software, professional contract services, neurostereology workshops, basic stereology courses, and online stereology webinars. The Center also offers tissue processing (sectioning, staining, slide preparation) and stereology data collection services. Researchers may use equipment and facilities to complete projects with full confidentiality and according to Good Laboratory Practices guidelines. | neurostereology, stereology, alzheimer's disease, parkinson's disease, neuronal morphology, neuronal stereology, microscopy, stereology consultation, webinar, workshop, tissue processing, sectioning, staining, slide preparation, data collection, tissue, slide | Alzheimer's disease, Parkinson's disease | Free, Freely available | nlx_156794, grid.492523.b | https://ror.org/02ez32078 | SCR_003137 | SRC - Better Science Through Better Stereology | 2026-09-19 12:50:12 | 4 | ||||||
|
Alzheimer Society of Canada Resource Report Resource Website 1+ mentions |
Alzheimer Society of Canada (RRID:SCR_000485) | institution | A nonprofit health organization that works to improve the quality of life of Canadians affected by Alzheimer's disease and other dementias. This organization also supports research on the cause and potential cures for the disease through education and funding. | dementia, alzheimer's, disease, research, funding, nonprofit, canada | Alzheimer's disease, Dementia | ISNI: 0000 0001 0702 2390, Crossref funder ID: 501100000143, nlx_158162, Wikidata: Q4738828, grid.453286.e | https://ror.org/03benss35 | SCR_000485 | 2026-09-19 12:49:24 | 2 | |||||||||
|
Boston University Alzheimer's Disease Center Neuropathology Core Facility Resource Report Resource Website |
Boston University Alzheimer's Disease Center Neuropathology Core Facility (RRID:SCR_000513) | biomaterial supply resource, brain bank, material resource, tissue bank | The Neuropathology Core leads neuropathological analyses of brains donated by research registry participants of the Boston University Alzheimer's Disease Center. The Core works with the Clinical Core to carry out the Brain Tissue Donation Program, which provides brain tissue for analyses that will help to understand the underlying pathology of AD. The Core also works closely with the Data Management and Statistics Core to maintain a comprehensive computerized database of information resulting from neuropathological analyses. The Boston University Brain Bank of the Neuropathology Core documents neuropathological findings of Center research registry participants, but also of brain donors from important related BUSM studies such as the Framingham Heart Study and the Centenarian Study. | alzheimers disease, brain tissue, clinical data, brain bank, database, material storage repository, core facility |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Boston University Alzheimer's Disease Center |
Alzheimer's disease | National Institute on Aging | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_33878 | SCR_000513 | Boston University Alzheimer's Disease Center - Neuropathology, BU ADC Neuropathology, BU ADC Neuropathology Core, BU Alzheimer's Disease Center - Neuropathology, Boston University Alzheimer's Disease Center - Neuropathology Core | 2026-09-19 12:49:25 | 0 | ||||||
|
Heptares Therapeutics Resource Report Resource Website |
Heptares Therapeutics (RRID:SCR_000499) | commercial organization | A drug discovery company focused on small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets. Heptares creates new medicines targeting previously undruggable or challenging GPCRs, a superfamily of receptors linked to many diseases. They are pioneering a structure-based drug design approach to GPCRs, leveraging proprietary technologies for protein stabilization, structure determination, and fragment-based discovery. Their partners include Cubist, MorphoSys, AstraZeneca, MedImmune and Takeda. Their objective is to build a broad pipeline of novel medicines to transform the treatment of serious diseases, including Alzheimer's disease, schizophrenia, diabetes, ADHD and chronic migraine. | g-protein coupled receptor, small molecule, drug, biotechnology, medicine, antibody, drug discovery | is related to: Kinetics for Drug Discovery | Alzheimer's disease, Schizophrenia, Diabetes, Attention deficit-hyperactivity disorder, Chronic migraine | nlx_158498, grid.450873.d, ISNI: 0000 0004 0456 4700 | https://ror.org/051fk5x88 | SCR_000499 | Heptares Therapeutics Limited, Heptares Therapeutics Ltd, Heptares | 2026-09-19 12:49:24 | 0 | |||||||
|
AlzProtect Resource Report Resource Website |
AlzProtect (RRID:SCR_000492) | AlzProtect | commercial organization | Commercial organization that develops drug candidates in the field of neurodegenerative diseases and particularly Alzheimer's. Their main objective is the development of a drug against Alzheimer's disease from molecules patented by Inserm and the University of Lille II. | late adult human, drug, molecule, neurodegeneration, medicine, drug development | is related to: PharmaCog | Alzheimer's disease, Aging, Neurodegenerative disease | nlx_158327 | SCR_000492 | Alz Protect, SAS AlzProtect, Alzprotect SAS, AlzProtect - Therapeutic Solutions for Neurodegeneration | 2026-09-19 12:49:24 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.